154 related articles for article (PubMed ID: 8714615)
1. Cladribine in the treatment of low-grade non-Hodgkin's lymphoma.
Piro LD
Semin Hematol; 1996 Jan; 33(1 Suppl 1):34-9. PubMed ID: 8714615
[No Abstract] [Full Text] [Related]
2. Cladribine for the treatment of indolent non-Hodgkin's lymphomas.
Hoffman MA
Semin Hematol; 1996 Jan; 33(1 Suppl 1):40-4. PubMed ID: 8714616
[No Abstract] [Full Text] [Related]
3. 2-Chlorodeoxyadenosine, a "novel" agent in the treatment of both lymphoid and myeloid malignancies.
Lauria F
Haematologica; 1992; 77(6):443-5. PubMed ID: 1363233
[No Abstract] [Full Text] [Related]
4. Use of bortezomib in B-cell non-Hodgkin's lymphoma.
Wang M; Zhou Y; Zhang L; Nguyen CA; Romaguera J
Expert Rev Anticancer Ther; 2006 Jul; 6(7):983-91. PubMed ID: 16831071
[TBL] [Abstract][Full Text] [Related]
5. Cladribine in indolent non-Hodgkin's lymphoma.
Sigal DS; Saven A
Expert Rev Anticancer Ther; 2008 Apr; 8(4):535-45. PubMed ID: 18402520
[TBL] [Abstract][Full Text] [Related]
6. 2-Chlorodeoxyadenosine treatment of lymphoma.
Saven A; Piro LD
Cancer Treat Res; 1996; 85():15-26. PubMed ID: 9043772
[No Abstract] [Full Text] [Related]
7. [Cladribine].
Ogura M
Gan To Kagaku Ryoho; 2003 Feb; 30(2):309-17. PubMed ID: 12610885
[TBL] [Abstract][Full Text] [Related]
8. 2-Chlorodeoxyadenosine: a potent antimetabolite with major activity in the treatment of indolent lymphoproliferative disorders.
Saven A; Piro LD
Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S93-101. PubMed ID: 9137962
[TBL] [Abstract][Full Text] [Related]
9. Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies.
Laurencet FM; Zulian GB; Guetty-Alberto M; Iten PA; Betticher DC; Alberto P
Br J Cancer; 1999 Mar; 79(7-8):1215-9. PubMed ID: 10098762
[TBL] [Abstract][Full Text] [Related]
10. The role of cladribine in the treatment of lymphoid malignancies.
Nelson MC; Hogan DK
Oncol Nurs Forum; 1995 Oct; 22(9):1395-400. PubMed ID: 8539180
[TBL] [Abstract][Full Text] [Related]
11. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment.
Shields DJ; Byrd JC; Abbondanzo SL; Lichy JH; Diehl LF; Aguilera NI
Mod Pathol; 1997 Nov; 10(11):1151-9. PubMed ID: 9388067
[TBL] [Abstract][Full Text] [Related]
12. Vorinostat (Zolinza) for cutaneous T-Cell lymphoma.
Med Lett Drugs Ther; 2007 Mar; 49(1256):23-4. PubMed ID: 17351559
[No Abstract] [Full Text] [Related]
13. Rituximab: review and clinical applications focusing on non-Hodgkin's lymphoma.
King KM; Younes A
Expert Rev Anticancer Ther; 2001 Aug; 1(2):177-86. PubMed ID: 12113023
[TBL] [Abstract][Full Text] [Related]
14. Marked increase in serum IgM during treatment of Waldenstrom's macroglobulinemia with cladribine.
Krishna VM; Carey RW; Bloch KJ
N Engl J Med; 2003 May; 348(20):2045-6. PubMed ID: 12748329
[No Abstract] [Full Text] [Related]
15. Clinical trials referral resource. Clinical trials in non-Hodgkin's Lymphoma.
Cheson BD; Smiley JK
Oncology (Williston Park); 1998 Sep; 12(9):1321-2, 1327. PubMed ID: 9778678
[No Abstract] [Full Text] [Related]
16. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma.
Kong LR; Huang CF; Hakimian D; Variakojis D; Klein L; Kuzel TM; Gordon LI; Zanzig C; Wollins E; Tallman MS
Cancer; 1998 Mar; 82(5):957-64. PubMed ID: 9486587
[TBL] [Abstract][Full Text] [Related]
17. Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
Leleu X; Soumerai J; Roccaro A; Hatjiharissi E; Hunter ZR; Manning R; Ciccarelli BT; Sacco A; Ioakimidis L; Adamia S; Moreau AS; Patterson CJ; Ghobrial IM; Treon SP
J Clin Oncol; 2009 Jan; 27(2):250-5. PubMed ID: 19064987
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment with 2-chlorodeoxyadenosine of secondary lesions of the central nervous system in low-grade lymphoid malignancies.
deCataldo F; Baudo F
Am J Hematol; 2002 Aug; 70(4):332-3. PubMed ID: 12210819
[No Abstract] [Full Text] [Related]
19. Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research Group.
Kalinka-Warzocha E; Wajs J; Lech-Maranda E; Ceglarek B; Holowiecki J; Federowicz I; Walewski J; Czyz J; Robak T; Warzocha K;
Cancer; 2008 Jul; 113(2):367-75. PubMed ID: 18470902
[TBL] [Abstract][Full Text] [Related]
20. Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma.
Eur J Cancer Care (Engl); 2003 Dec; 12(4):306-7. PubMed ID: 14982308
[No Abstract] [Full Text] [Related]
[Next] [New Search]